Anthropometric features are not predictive of 72-hour fast duration in insulinomas

Diane Donegan, Iva Jakubikova, Adrian Vella

Research output: Contribution to journalArticle

Abstract

Objective: The 72-hour fast is used to document Whipple's triad and understand the mechanism of hypoglycemia. Although hypoglycemia develops within 24 hours in the majority of fasts, identifying possible determinants of fast duration may help to predict the need for admission. Therefore, we determined the relation between anthropometric features on fast duration and assessed end of fast parameters on maximal tumor size, extent of disease, or tumor recurrence. Methods: A retrospective analysis of patients with insulinoma in the past 25 years who underwent a 72-hour fast was conducted. Electronic medical records were reviewed to obtain anthropometric patient data and tumor characteristics. Results: A total of 233 patients underwent the 72-hour fast. The mean age at diagnosis was 50 ± 16 years, with a body mass index (BMI) of 29 ± 7 kg/m2, and 66% (153 of 233) were female. Duration of fast was not associated with gender (P = .2), age (P = .3), or BMI (P = .7). A shorter fast duration was inversely related to end of fast C-peptide (P = .0075) but not insulin (P = .13) or proinsulin (P = .28) concentration. End of fast C-peptide was associated with increased tumor size (P = .036) and multiplicity (P =.01). Proinsulin was associated with increased tumor size (P<.01) and malignancy (P = .018). Conclusion: Duration of fast was not significantly related age, gender, weight, or BMI, although end-of-fast C-peptide and proinsulin may provide some information regarding tumor characteristics. Consequently, the duration of fast cannot be predicted a priori and should be allowed to run for the planned length unless hypoglycemia develops.

Original languageEnglish (US)
Pages (from-to)923-928
Number of pages6
JournalEndocrine Practice
Volume23
Issue number8
DOIs
StatePublished - Aug 1 2017

Fingerprint

Insulinoma
C-Peptide
Hypoglycemia
Neoplasms
Proinsulin
Body Mass Index
Electronic Health Records
Insulin
Weights and Measures
Recurrence

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this

Anthropometric features are not predictive of 72-hour fast duration in insulinomas. / Donegan, Diane; Jakubikova, Iva; Vella, Adrian.

In: Endocrine Practice, Vol. 23, No. 8, 01.08.2017, p. 923-928.

Research output: Contribution to journalArticle

Donegan, Diane ; Jakubikova, Iva ; Vella, Adrian. / Anthropometric features are not predictive of 72-hour fast duration in insulinomas. In: Endocrine Practice. 2017 ; Vol. 23, No. 8. pp. 923-928.
@article{d9e9035a89854944b6ee0f5906dbd188,
title = "Anthropometric features are not predictive of 72-hour fast duration in insulinomas",
abstract = "Objective: The 72-hour fast is used to document Whipple's triad and understand the mechanism of hypoglycemia. Although hypoglycemia develops within 24 hours in the majority of fasts, identifying possible determinants of fast duration may help to predict the need for admission. Therefore, we determined the relation between anthropometric features on fast duration and assessed end of fast parameters on maximal tumor size, extent of disease, or tumor recurrence. Methods: A retrospective analysis of patients with insulinoma in the past 25 years who underwent a 72-hour fast was conducted. Electronic medical records were reviewed to obtain anthropometric patient data and tumor characteristics. Results: A total of 233 patients underwent the 72-hour fast. The mean age at diagnosis was 50 ± 16 years, with a body mass index (BMI) of 29 ± 7 kg/m2, and 66{\%} (153 of 233) were female. Duration of fast was not associated with gender (P = .2), age (P = .3), or BMI (P = .7). A shorter fast duration was inversely related to end of fast C-peptide (P = .0075) but not insulin (P = .13) or proinsulin (P = .28) concentration. End of fast C-peptide was associated with increased tumor size (P = .036) and multiplicity (P =.01). Proinsulin was associated with increased tumor size (P<.01) and malignancy (P = .018). Conclusion: Duration of fast was not significantly related age, gender, weight, or BMI, although end-of-fast C-peptide and proinsulin may provide some information regarding tumor characteristics. Consequently, the duration of fast cannot be predicted a priori and should be allowed to run for the planned length unless hypoglycemia develops.",
author = "Diane Donegan and Iva Jakubikova and Adrian Vella",
year = "2017",
month = "8",
day = "1",
doi = "10.4158/EP171872.OR",
language = "English (US)",
volume = "23",
pages = "923--928",
journal = "Endocrine Practice",
issn = "1530-891X",
publisher = "American Association of Clinical Endocrinology",
number = "8",

}

TY - JOUR

T1 - Anthropometric features are not predictive of 72-hour fast duration in insulinomas

AU - Donegan, Diane

AU - Jakubikova, Iva

AU - Vella, Adrian

PY - 2017/8/1

Y1 - 2017/8/1

N2 - Objective: The 72-hour fast is used to document Whipple's triad and understand the mechanism of hypoglycemia. Although hypoglycemia develops within 24 hours in the majority of fasts, identifying possible determinants of fast duration may help to predict the need for admission. Therefore, we determined the relation between anthropometric features on fast duration and assessed end of fast parameters on maximal tumor size, extent of disease, or tumor recurrence. Methods: A retrospective analysis of patients with insulinoma in the past 25 years who underwent a 72-hour fast was conducted. Electronic medical records were reviewed to obtain anthropometric patient data and tumor characteristics. Results: A total of 233 patients underwent the 72-hour fast. The mean age at diagnosis was 50 ± 16 years, with a body mass index (BMI) of 29 ± 7 kg/m2, and 66% (153 of 233) were female. Duration of fast was not associated with gender (P = .2), age (P = .3), or BMI (P = .7). A shorter fast duration was inversely related to end of fast C-peptide (P = .0075) but not insulin (P = .13) or proinsulin (P = .28) concentration. End of fast C-peptide was associated with increased tumor size (P = .036) and multiplicity (P =.01). Proinsulin was associated with increased tumor size (P<.01) and malignancy (P = .018). Conclusion: Duration of fast was not significantly related age, gender, weight, or BMI, although end-of-fast C-peptide and proinsulin may provide some information regarding tumor characteristics. Consequently, the duration of fast cannot be predicted a priori and should be allowed to run for the planned length unless hypoglycemia develops.

AB - Objective: The 72-hour fast is used to document Whipple's triad and understand the mechanism of hypoglycemia. Although hypoglycemia develops within 24 hours in the majority of fasts, identifying possible determinants of fast duration may help to predict the need for admission. Therefore, we determined the relation between anthropometric features on fast duration and assessed end of fast parameters on maximal tumor size, extent of disease, or tumor recurrence. Methods: A retrospective analysis of patients with insulinoma in the past 25 years who underwent a 72-hour fast was conducted. Electronic medical records were reviewed to obtain anthropometric patient data and tumor characteristics. Results: A total of 233 patients underwent the 72-hour fast. The mean age at diagnosis was 50 ± 16 years, with a body mass index (BMI) of 29 ± 7 kg/m2, and 66% (153 of 233) were female. Duration of fast was not associated with gender (P = .2), age (P = .3), or BMI (P = .7). A shorter fast duration was inversely related to end of fast C-peptide (P = .0075) but not insulin (P = .13) or proinsulin (P = .28) concentration. End of fast C-peptide was associated with increased tumor size (P = .036) and multiplicity (P =.01). Proinsulin was associated with increased tumor size (P<.01) and malignancy (P = .018). Conclusion: Duration of fast was not significantly related age, gender, weight, or BMI, although end-of-fast C-peptide and proinsulin may provide some information regarding tumor characteristics. Consequently, the duration of fast cannot be predicted a priori and should be allowed to run for the planned length unless hypoglycemia develops.

UR - http://www.scopus.com/inward/record.url?scp=85029811626&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85029811626&partnerID=8YFLogxK

U2 - 10.4158/EP171872.OR

DO - 10.4158/EP171872.OR

M3 - Article

VL - 23

SP - 923

EP - 928

JO - Endocrine Practice

JF - Endocrine Practice

SN - 1530-891X

IS - 8

ER -